Sarepta Avoids IP Claims As Judge Finds UPenn Patent Invalid

By Kelly Lienhard · January 5, 2024, 9:03 PM EST

A Delaware judge found a gene therapy patent at the center of an infringement suit against Sarepta, brought by the University of Pennsylvania, was ineligible for patent protection because the claims...

To view the full article, register now.

Documents

Case Information

Case Title

REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al.

Case Number

1:20-cv-01226

Court

Delaware

Nature of Suit

Patent

Date Filed

September 15, 2020